Eldridge Investment Advisors, Inc. Johnson & Johnson Transaction History

Eldridge Investment Advisors, Inc.

$426 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$144.38 - $157.78 $6,785 - $7,415	-47 Reduced 3.22%	1,414 $207,000
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $17,074 - $17,901	110 Added 8.14%	1,461 $231,000
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $8,590 - $9,373	-59 Reduced 4.18%	1,351 $212,000
Q2 2023 Aug 03, 2023	SELL	$154.35 - $166.11 $61,740 - $66,444	-400 Reduced 22.1%	1,410 $233,000
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $3,776 - $4,506	-25 Reduced 1.36%	1,810 $281,000
Q4 2022 Feb 03, 2023	BUY	$160.2 - $179.79 $16,019 - $17,979	100 Added 5.76%	1,835 $324,000
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $3,520 - $3,921	-23 Reduced 1.31%	1,735 $285,000
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $2,947 - $3,230	-21 Reduced 1.18%	1,758 $262,000
Q2 2020 Aug 07, 2020	BUY	$128.81 - $155.51 $2,705 - $3,265	21 Added 1.19%	1,779 $250,000
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $1,111 - $1,539	10 Added 0.57%	1,758 $231,000
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $9,394 - $10,518	-74 Reduced 4.06%	1,748 $226,000
Q2 2019 Jul 29, 2019	BUY	$131.15 - $144.24 $12,590 - $13,847	96 Added 5.56%	1,822 $254,000
Q1 2019 Apr 24, 2019	BUY	$125.72 - $139.79 $216,992 - $241,277	1,726 New	1,726 $241,000
Q4 2018 Jan 24, 2019	SELL	$122.84 - $147.84 $256,735 - $308,985	-2,090 Closed	0 $0
Q3 2018 Oct 11, 2018	BUY	$121.58 - $142.88 $254,102 - $298,619	2,090 New	2,090 $288,000
Q2 2018 Jul 31, 2018	SELL	$119.4 - $131.76 $215,517 - $237,826	-1,805 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $28,397 - $33,627	227 Added 14.39%	1,805 $231,000
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $207,065 - $226,632	1,578	1,578 $219,000

Others Institutions Holding JNJ

# of Institutions

4,253

Shares Held

1.68B

Call Options Held

14M

Put Options Held

11.8M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldridge Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eldridge Investment Advisors, Inc. with notifications on news.

Account